-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vcet6eCensiGvDFx/XwihQsrbBd6oAT93BeLxe3bgczzdO/hQIfHtXwMZZhu3dA0 SRXnK3f9RojVZUHBr02fyw== 0000930413-10-002774.txt : 20100507 0000930413-10-002774.hdr.sgml : 20100507 20100507162223 ACCESSION NUMBER: 0000930413-10-002774 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100506 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20100507 DATE AS OF CHANGE: 20100507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 10812738 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 8-K 1 c61488_8k.htm c61488_8k.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
____________________________

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): May 6, 2010

____________________________

Quest Diagnostics Incorporated
(Exact Name of Registrant as Specified in Its Charter)
___________________________

Delaware
(State or other jurisdiction of Incorporation)

001-12215 16-1387862
(Commission File Number) (I.R.S. Employer Identification No.)
 
 
Three Giralda Farms  
Madison, NJ 07940 07940
(Address of principal executive offices) (Zip Code)

(973) 520-2700
(Registrant’s telephone number, including area code)
___________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction a.2. below):

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     

Item 5.07. Submission of Matters to a Vote of Security Holders

(a)     

The Annual Meeting of Shareholders of the Quest Diagnostics Incorporated (the “Company”) was held on May 6, 2010.
 
(b)     

The following nominees for the office of director were elected for terms expiring at the 2013 Annual Meeting of Shareholders, by the following votes:
 
    For       Against       Abstain       Broker Non-Vote
                 
  John C. Baldwin, M.D. 141,330,276   1,470,103   394,471   10,239,051
                 
  Surya N. Mohapatra, Ph.D. 139,118,067   3,738,652   338,131   10,239,051
                 
  Gary M. Pfeiffer 140,153,918   2,625,564   415,368   10,239,051

The following persons also continue as directors:

Jenne K. Britell, Ph.D.
William F. Buehler
Rosanne Haggerty
Daniel C. Stanzione, Ph.D.
Gail R. Wilensky, Ph.D.
John B. Ziegler

The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm to audit the financial statements of the Company and its subsidiaries for the fiscal year ending December 31, 2010 was approved by the following votes:

For   Against   Abstain
151,387,328   1,708,912   337,661

Signature

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  May 7, 2010
 
  QUEST DIAGNOSTICS INCORPORATED
     
  By: /s/ William J. O’Shaughnessy, Jr.
    William J. O’Shaughnessy, Jr.
    Assistant General Counsel and
    Secretary

-----END PRIVACY-ENHANCED MESSAGE-----